MARUX CONTINUOUS BIOMANUFACTURING
Live / Applied — Non-final action written — not yet mailed (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 03 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79441470
- Mark type
- Design + words
- Filed
- 03 Nov 2025
Goods and services
- Class 040 — Treatment of materials: Continuous production, including continuous manufacture and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others; continuous expression, isolation and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others; continuous connected upstream and downstream production of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others.
- Class 042 — Scientific and technological services: Scientific, industrial and technical research, development and analysis services related to continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; process development related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; industrial design services related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; provision of facilities for scientific, industrial and technical research development related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells.
Owner
Prosecution history
- 21 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 20 Mar 2026 — NON-FINAL ACTION WRITTEN
- 16 Mar 2026 — ASSIGNED TO EXAMINER
- 18 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 18 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Jan 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB